C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
01/2003
01/14/2003	US6506744 Benzazepinone-derivatives
01/09/2003	WO2003002532A1 Cyclic diamine compounds having fused-ring groups
01/09/2003	WO2002059102A3 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use
01/08/2003	EP1273575A1 Diazepane derivatives or salts thereof
01/08/2003	EP1273298A2 Ritonavir in combination with an additional HIV protease inhibitor for treating aids
01/08/2003	EP1272176A1 Adamantyl derivatives as anti-cancer agents
01/08/2003	EP1272175A2 Il-8 receptor antagonists
01/07/2003	US6503902 Treatment of neurological disorders related to beta -amyloid production such as Alzheimer's disease and Down's Syndrome.
01/07/2003	US6503901 Amino lactam sulfonamides as inhibitors of Aβ protein production
01/07/2003	US6503900 [1,4]diazepino [6,7,1-jk ]carbazoles and derivatives
01/07/2003	US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection
01/07/2003	US6503897 N-Formylhydroxylamine derivatives; veterinary medicine; grampositive and gramnegative bacteria
01/07/2003	US6503759 Encoded combinatorial chemistry is provided, where sequential synthetic schemes are recorded using organic molecules, which define choice of reactant, and stage, as the same or different bit of information. Various products can be produced in the
01/03/2003	WO2002088101A3 Inhibitors of bace
01/03/2003	WO2002060870A3 Delta agonist analgesics
01/02/2003	EP1268517A2 Process for the preparation of 3-amino-1,5-benzodiazepine derivatives
01/02/2003	EP1268450A1 Lactams substituted by cyclic succinates as inhibitors of a-beta protein production
01/02/2003	EP1268434A1 Cyclic lactams as inhibitors of a-beta protein production
01/02/2003	EP1268433A1 Cyclic lactams as inhibitors of a-beta-protein production
12/2002
12/31/2002	US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
12/27/2002	WO2002102380A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
12/27/2002	CA2429113A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
12/26/2002	US20020198197 Metabotropic glutamate receptor agonist for treatment or prevention of acute and/or chronic neurological disorders
12/26/2002	US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/26/2002	US20020198191 Cyclohexylphenyl vasopressin agonists
12/24/2002	US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system
12/19/2002	WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
12/19/2002	WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002	US20020193382 Sulfonamide derivatives, their production and use
12/19/2002	US20020193367 Dihydro-benzo [b] [1,4] diazepin-2-one derivatives
12/19/2002	CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/18/2002	EP1265875A2 Process for preparing pure crystalline lorazepam
12/18/2002	CN1386118A Lactams substituted by cyclic succinates as inhibitors of A beta protein production
12/18/2002	CN1096464C 2,3-benzodiazepine derivatives, its preparation and intermediate and use as medicine
12/18/2002	CN1096459C (R)-5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1, 4-diazepin-6-YL)-2-methoxy-6-methylamino-3-pyridine-carboxamide
12/17/2002	US6495541 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/12/2002	WO2002099388A2 Benzodiazepine bradykinin antagonists
12/12/2002	WO2002098865A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/12/2002	CA2446696A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/11/2002	EP1023072B1 Analgesic compositions comprising a cholecystokinin and an opioid
12/10/2002	US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002	US6492355 Adamantane derivatives
12/05/2002	WO2002036073A3 Receptor antagonist-lipid conjugates and delivery vehicles containing same
12/05/2002	US20020183514 Useful in the treatment and control of solid tumors
12/05/2002	US20020183324 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
12/05/2002	US20020183313 Cholecystokinin-A and B (CCK-A/B) antagonists and useful in therapy and prophylaxis of disorders of appetite regulatory systems (e.g., anorexia) disorders associated with intestinal smooth muscle hyperactivity (e.g., irritable bowel syndrome)
12/04/2002	EP1262184A1 Compositions comprising S-tofisopam and use of these compositions for the preparation of a medicament for the treatment or prevention of convulsions or seizures
12/04/2002	EP1261610A2 Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production
11/2002
11/28/2002	WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	WO2002094189A2 Compositions and methods for treating or preventing convulsions or seizures
11/28/2002	US20020177609 Fatty alcohol drug conjugates
11/28/2002	US20020177600 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
11/28/2002	CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/27/2002	EP1259492A1 Substituted piperazine derivatives as mtp inhibitors
11/27/2002	EP1153050A4 Amino-ketone solid support templates
11/27/2002	CN1382126A Bleach boosting components, compositions and laundry methods
11/27/2002	CN1382125A Bicycle vasporession agonists
11/21/2002	WO2002092585A1 Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/21/2002	WO2002092096A1 Antitumor agents
11/21/2002	WO2002022598A8 Quinolinone derivatives as tyrosine kinase inhibitors
11/21/2002	CA2445477A1 Antitumor agents
11/20/2002	EP0593603B1 Bicyclic fibrinogen antagonists
11/19/2002	US6482944 By direct reaction of an amine with an alpha, gamma-dihaloalkane or an alpha, gamma-dihaloalkene; tertiary aminoalkylorganometallics can be made by then reacting the tert haloalkylamines with an alkali metals
11/19/2002	US6482821 Antiinflammatory agents; antitumor agents; cardiovacular disorders
11/19/2002	CA2138308C Preparation of hexahydroazepinones and hexahydroazepinoles
11/18/2002	CA2381637A1 Compositions and methods for treating or preventing convulsions or seizures
11/13/2002	CN1379765A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist
11/13/2002	CN1379764A Benzodiazepine derivatives
11/12/2002	US6479608 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
11/07/2002	WO2002088115A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
11/07/2002	WO2002088101A2 Inhibitors of bace
11/07/2002	WO2002088096A1 Compounds inhibiting cyclic nucleotide phosphodiesterases, preparation and uses thereof
11/07/2002	WO2001042243A3 Protein kinase inhibitors
11/06/2002	EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254108A1 Gamma-secretase inhibitors
11/06/2002	EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/05/2002	US6476017 (dibenzo(b,e)(1,4)-diazepine-11-yl)benzoic acid derivatives
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002069895A3 Heterocyclic analgesic compounds and methods of use thereof
10/31/2002	WO2001056563A9 Adamantyl derivatives as anti-cancer agents
10/30/2002	EP1105359B1 Solid phase synthesis of compounds by carbon-carbon bond forming mitsunobu reactions
10/29/2002	US6472529 Viricides
10/29/2002	CA2158763C Novel process for preparation of clonidine derivatives
10/24/2002	WO2002083685A1 Cyclohexylphenyl vasopressin agonists
10/24/2002	WO2002083665A1 DIHYDRO-BENZO[b][1,4]DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
10/24/2002	WO2002083652A1 DIHYDRO-BENZO [b] [1, 4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
10/24/2002	WO2002083145A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002	US20020156212 Catalyst systems of alpha -diimine, urethane or urea ligands complexed to nickel, palladium or other transition metals
10/24/2002	US20020156052 Tricyclic opiod receptor agonists
10/24/2002	CA2444455A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002	CA2443870A1 Cyclohexylphenyl vasopressin agonists
10/23/2002	EP1250324A1 Biaryl compounds, their preparation and their use in therapy
10/23/2002	EP1000067B1 Thiazolobenzoheterocycles, preparation and medicines containing same
10/23/2002	EP0923561B1 Heterocyclic metalloprotease inhibitors
10/22/2002	US6469000 1,3-diheterocyclic metalloprotease inhibitors
10/17/2002	WO2002081457A1 `1,4!-diazepane-1-carboxylic acid derivatives process for their preparation and their use as tachykinin antagonists
10/16/2002	EP0538297B9 Antiviral tetrahydroimidazo 1,4]benzodiazepin-2-(thio)ones
10/16/2002	CN1374960A Novel integrain receptor antagonists
10/15/2002	US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis

1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 60